Citius Pharmaceuticals Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$0.58

-0.02 (-3.92%)

As of Sep 21, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +567.8% upside

Low Target $3.27

Average Target $3.85

High Target $6.37

Current Price $0.58

Current
$0.58

Target
$3.85

$3.27 $3.85 avg $6.37

Scenario Analysis

Bear Case

$3.27

467.2%

Low target

Base Case

$3.85

+567.8%

Avg target

Bull Case

$6.37

+1,004.9%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$2.19

-73.7% from high

52-Week Low

$0.47

+23.0% from low

Target vs 52W High

$3.85

+75.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+14.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.2%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+6.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+22.2%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+178.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+194.2%